alexa Enabling Tools For Gene Therapy Viral Vector Development
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

6th International Conference and Exhibition on Cell and Gene Therapy
March 27-28, 2017 Madrid, Spain

Ana Sofia Coroadinha
iBET - Instituto de Biologia Experimental e Tecnológica, Portugal
ScientificTracks Abstracts: J Stem Cell Res Ther
DOI: 10.4172/2157-7633.C1.023
Abstract
Virus-Based Biopharmaceuticals (VBBs) produced in animal cells such as oncolytic vectors, virus-like particle vaccines and gene transfer vectors are among the most promising bioproducts. Gene therapy viral vectors interest and investment has grown significantly leveraged by, the recent approvals of gene therapeutic products Glybera and Strimvelis and by the very encouraging results obtained with Chimeric Antigen Receptor (CAR)-T cells in cancer treatments. For the successful marketing of gene therapy, viral vectors enhanced and competitive manufacturing processes are required. On the other hand VBBs development can be cumbersome. The establishment of cell lines for virus production is an intensive and time consuming work. In addition, virus titration methods are laborious and often lack accuracy. In our research, we are developing novel enabling technologies that contribute for the progress in viral vector and cell line development. Different approaches can be used in cell line development. We have been using targeted integration and recently developed a high throughput cell line screening technology, the Single-Step Cloning Screening technology (SSCS). The SSCS merges cloning and screening by using split-GFP, a green fluorescent protein separated into 2 fragments which fluoresce upon transcomplementation. It can be used in cell line development, cell engineering as well as in vector engineering. We could obtain retroviral vector clones producing 1x108 infectious particles per mL and improved IP/TP ratios. To further expand SSCS approach to other virus and in order to quantify virus we are developing Visensors. The latter are cell based biosensors for label-free virus. Herein we will present and discuss these novel technologies which face the state of the art methodologies and how they can contribute for faster development of viral vectors for gene therapy.
Biography

Ana Sofia Coroadinha has a Degree in Biochemistry and completed her PhD in Gene Therapy in a tripartite felowship between Généthon, Helmholtz Centre for Infection Research (HZI) and iBET. She became Director of the Cell Line Development and Molecular Biotechnology Laboratory (iBET and ITQB-UNL). Her research is focused on developing virus based biopharmaceuticals for vaccine and gene therapy purposes. She has published more than 40 papers in reputed journals and has been serving as an Editorial Board Member of reputed Biotechnology Letters and Scientific Reports journals.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords